Showing results (111-120 of 135) with videos related to
Sort By:
Pageof 14
Radiology|February 1, 1992
Lymphoma: predictive value of Ga-67 scintigraphy after treatmentD Front, S Ben-Haim, O Israel, et al.Clinical Nuclear Medicine|May 1, 1990
Normal and abnormal Ga-67 SPECT anatomy in patients with lymphomaO Israel, J Jerushalmi, S Ben-Haim, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Human sarcoma-associated murine monoclonal antibody labeled with indium-111, gallium-67, and iodine-125A H Bartal, E Lavie, M Boazi, et al.Radiology|April 20, 1999
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapyD Front, R Bar-Shalom, M Mor, et al.Radiology|January 22, 2000
Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphyD Front, R Bar-Shalom, M Mor, et al.Cancer|May 15, 1991
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumorsD Front, E Even-Sapir, O Israel, et al.Radiology|October 1, 1987
Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptakeD Front, O Israel, G Iosilevsky, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1990
Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and menD Front, O Israel, G Iosilevsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Quantitative bone single-photon emission computed tomography for prediction of pain relief in metastatic bone disease treated with rhenium-186 etidronateO Israel, Z Keidar, R Rubinov, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1994
SPECT quantitation of cobalt-57-bleomycin to predict treatment response and outcome of patients with lung cancerE Even-Sapir, L Bettman, G Iosilevsky, et al.Pageof 14